重點成果

重點成果

• 
  2022-01-21 重點成果

  Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung Cancer

  蕭宏昇
  Frontiers in Oncology

• 
  2022-01-20 重點成果

  Structural and Mechanistic Bases for StnK3 and Its Mutant-Mediated Lewis-Acid-Dependent Epimerization and Retro-Aldol Reactions

  李宗璘
  ACS Catalysis

• 
  2022-01-18 重點成果

  Integrated therapy platform of exosomal system: hybrid inorganic/organic nanoparticles with exosomes for cancer treatment

  蕭宏昇
  Nanoscale Horizons

• 
  2022-01-14 重點成果

  Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B

  楊懷壹, 陳建仁
  AP&T Alimentary Pharmacology & Therapeutics

• 
  2021-12-14 重點成果

  Homogeneous antibody and CAR-T cell targeting glycan on pancreatic cancer

  翁啟惠
  PNAS

• 
  2021-11-24 重點成果

  Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection

  楊懷壹, 陳建仁
  JHEP Reports

• 
  2021-11-23 重點成果

  Novel monodisperse FePt nanocomposites for T2-weighted magnetic resonance imaging: biomedical theranostics applications

  蕭宏昇
  Nanoscale Advances

• 
  2021-10-15 重點成果

  Immunogenicity evaluation of N-glycans recognized by HIV broadly neutralizing antibodies

  翁啟惠
  ACS Chemical Biology

• 
  2021-10-09 重點成果

  Magnetically Guided Theranostics: Montmorillonite-Based Iron/Platinum Nanoparticles for Enhancing in Situ MRI Contrast and Hepatocellular Carcinoma Treatment

  蕭宏昇
  Journal of Nanobiotechnology

• 
  2021-08-20 重點成果

  Combined effect of anti-SSEA4 and anti-Globo H antibodies on breast cancer cells

  翁啟惠
  ACS Chemical Biology